Drug Database
Back to search

Netherlands· NL-484aff6ba77c

Kolbam 250 mg, capsule, hard

A cholic acid product containing cholzuur, registered in Netherlands by Retrophin Europe Limited. The same ATC class is registered in 11 of our 19 countries.

ATC A05AA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedKolbam 250 mg, capsule, hardATCA05AA03REGISTER NO.NL-484aff6ba77cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cholzuurAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cholic acid is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AA03 (cholic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search cholic acid products by name

Cholic acid · ATC A05AA03

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CHOLZUUR
Manufacturer
Retrophin Europe Limited
Country
Netherlands (NL)
ATC code
A05AA03
ATC class
Cholic acid
Defined daily dose
0.25 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/13/895

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

12 interactions on record for cholic acid.

Graded by severity as the source publishes them — 12 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cholic acid against other medicinesHow interaction checks work

Cholic acid · interactions on record

12 records

  • 12 moderate

Most severe, free to view

  • SucralfateA02BX02moderate
  • ColestyramineC10AC01moderate
  • ColestipolC10AC02moderate
  • ColesevelamC10AC04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cholic acid in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cholic acid products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Orphacol
  • Iceland · Orphacol
  • Liechtenstein · Orphacol
  • Norway · Orphacol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed45a097-3539-4775-9bd0-766512d6fa4d
GET /v1/drugs/ed45a097-3539-4775-9bd0-766512d6fa4d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kolbam-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Cholic acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp111757",
  "excipients": [
    "AMMONIA (E 527)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "CHOLZUUR"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/04/04",
  "procedure_number": "EMEA/H/C/002081",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/13/895",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cholic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console